Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland
· Delayed Price · Currency is CHF
18.28
-0.24 (-1.30%)
Dec 5, 2025, 5:30 PM CET
Newron Pharmaceuticals Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 25.33 | 15.84 | -16.22 | -17.49 | -14.9 | -21 | |
| Depreciation & Amortization | 0.18 | 0.19 | 0.2 | 0.2 | 0.21 | 0.22 | |
| Stock-Based Compensation | 0.24 | 0.26 | 0.2 | 0.48 | 0.76 | 1.46 | |
| Other Operating Activities | 4.54 | 3.85 | 4.17 | 3.83 | 2.75 | 0.01 | |
| Change in Accounts Receivable | -9.39 | -44.22 | -1.31 | -0.88 | 1.75 | 1.23 | |
| Change in Accounts Payable | -0.68 | 2.63 | 0.58 | 0.58 | -3.95 | 0.56 | |
| Change in Other Net Operating Assets | 4.34 | 3.84 | 2.24 | 2.19 | 1.93 | 1.94 | |
| Operating Cash Flow | 24.57 | -17.61 | -10.14 | -11.09 | -11.45 | -15.59 | |
| Capital Expenditures | -0.04 | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | |
| Sale (Purchase) of Intangibles | -0 | - | - | - | - | -0 | |
| Investment in Securities | -12.37 | 3.17 | 3.26 | -0.3 | 8.44 | -0.58 | |
| Investing Cash Flow | -12.4 | 3.16 | 3.25 | -0.32 | 8.42 | -0.62 | |
| Long-Term Debt Issued | - | - | - | - | 15 | 7.5 | |
| Long-Term Debt Repaid | - | -0.19 | -0.19 | -0.19 | -0.17 | -0.14 | |
| Net Debt Issued (Repaid) | -0.19 | -0.19 | -0.19 | -0.19 | 14.83 | 7.37 | |
| Issuance of Common Stock | 6.77 | 15.41 | - | - | - | - | |
| Other Financing Activities | - | -0.17 | - | - | - | - | |
| Financing Cash Flow | 6.58 | 15.05 | -0.19 | -0.19 | 14.83 | 7.37 | |
| Net Cash Flow | 18.74 | 0.6 | -7.09 | -11.6 | 11.81 | -8.84 | |
| Free Cash Flow | 24.53 | -17.63 | -10.15 | -11.11 | -11.47 | -15.62 | |
| Free Cash Flow Margin | 40.97% | -34.30% | -112.08% | -182.31% | -198.98% | -297.11% | |
| Free Cash Flow Per Share | 1.15 | -0.86 | -0.57 | -0.62 | -0.64 | -0.88 | |
| Cash Interest Paid | 1.04 | 1.9 | 1.2 | 1.23 | 0.87 | 0.61 | |
| Levered Free Cash Flow | 11.25 | -26.67 | -9.22 | -9.64 | -10.04 | -10.14 | |
| Unlevered Free Cash Flow | 14 | -23.95 | -6.61 | -7.17 | -8.22 | -8.74 | |
| Change in Working Capital | -5.73 | -37.75 | 1.51 | 1.89 | -0.26 | 3.72 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.